Bellevue Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.9M | Buy |
|
|||||
|
2025
Q1 | $17.4M | Buy |
|
|||||
|
2024
Q4 | $14.1M | Sell |
|
|||||
|
2024
Q3 | $46.5M | Sell |
|
|||||
|
2024
Q2 | $55M | Buy |
|
|||||
|
2024
Q1 | $51.1M | Sell |
|
|||||
|
2023
Q4 | $50.8M | Sell |
|
|||||
|
2023
Q3 | $75.7M | Buy |
|
|||||
|
2023
Q2 | $45.5M | Buy |
|
|||||
|
2023
Q1 | $42.7M | Sell |
|
|||||
|
2022
Q4 | $76.6M | Sell |
|
|||||
|
2022
Q3 | $92M | Sell |
|
|||||
|
2022
Q2 | $101M | Sell |
|
|||||
|
2022
Q1 | $202M | Sell |
|
|||||
|
2021
Q4 | $211M | Sell |
|
|||||
|
2021
Q3 | $177M | Buy |
|
|||||
|
2021
Q2 | $178M | Buy |
|
|||||
|
2021
Q1 | $138M | Buy |
|
|||||
|
2020
Q4 | $108M | Sell |
|
|||||
|
2020
Q3 | $93.8M | Buy |
|
|||||
|
2020
Q2 | $81.5M | Sell |
|
|||||
|
2020
Q1 | $83M | Buy |
|
|||||
|
2019
Q4 | $98.2M | Buy |
|
|||||
|
2019
Q3 | $73.5M | Sell |
|
|||||
|
2019
Q2 | $102M | Buy |
|
|||||
|
2019
Q1 | $73.2M | Buy |
|
|||||
|
2018
Q4 | $61.1M | Buy |
|
|||||
|
2018
Q3 | $61.4M | Buy |
|
|||||
|
2018
Q2 | $50.8M | Buy |
|
|||||
|
2018
Q1 | $39.8M | Hold |
|
|||||
|
2017
Q4 | $40.8M | Buy |
|
|||||
|
2017
Q3 | $32.5M | Buy |
|
|||||
|
2017
Q2 | $23.2M | Buy |
|
|||||
|
2017
Q1 | $18.3M | Buy |
|
|||||
|
2016
Q4 | $2.96M | Hold |
|
|||||
|
2016
Q3 | $2.58M | Buy |
|
|||||
|
2016
Q2 | $1.84M | Sell |
|
|||||
|
2016
Q1 | $4.17M | Buy |
|